Urine volume to hydration volume ratio is associated with pharmacokinetics of high‐dose methotrexate in patients with primary central nervous system lymphoma-Reference-Cited by-同舟云学术

Urine volume to hydration volume ratio is associated with pharmacokinetics of high‐dose methotrexate in patients with primary central nervous system lymphoma

Published:2021-10-19 Issue:6 Volume:9 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Isono Tetsuichiro¹^ORCID,Hira Daiki¹²^ORCID,Morikochi Aya¹,Fukami Tadateru³,Ueshima Satoshi²,Nozaki Kazuhiko³,Terada Tomohiro¹,Morita Shin‐ya¹^ORCID

Affiliation:

1. Department of Pharmacy Shiga University of Medical Science Hospital Otsu Shiga Japan

2. College of Pharmaceutical Sciences Ritsumeikan University Kusatsu Shiga Japan

3. Department of Neurosurgery Shiga University of Medical Science Otsu Shiga Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.883

Reference49 articles.

1. Brain Tumor Registry of Japan (2005‐2008);Neurol Med Chir,2017

2. Trends in survival from primary central nervous system lymphoma, 1975-1999

3. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas

4. Combined-modality therapy for primary central nervous system lymphoma: Long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group)

5. Implications of the blood–brain barrier in primary central nervous system lymphoma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review;European Journal of Clinical Pharmacology;2023-11-07

2. External evaluation and systematic review of population pharmacokinetic models for high-dose methotrexate in cancer patients;European Journal of Pharmaceutical Sciences;2023-07